16.4101.99% ( +0.320 )
Trading: Nov 16, 11:34:58 (EDT)Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Bambusa Therapeutics(BBTX) the EBIT is -11.27 M (-58.64%);the EPS is -1.98 (--%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B58.64%
----
----
EPS
-1.9789--
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateDec 16, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
